Drug class

Pyrimidine Analogs

Pyrimidine analogs are a subclass of antimetabolite drugs structurally designed to mimic endogenous pyrimidines such as uracil, thymine, and cytosine. Read more about Pyrimidine Analogs

100 drugs in this class 55 manufacturers

Advertisement

Drugs in Pyrimidine Analogs

Showing 82–90 of 100 drugs

AZACITIDINE

PYRIMIDINE ANALOGS · MYELODYSPLASTIC SYNDROME ·+2
BLUEPOINT/ONCOP

CAPECITABINE

5 FLUOROPYRIMIDINES · MALIGNANT ESOPHAGEAL NEOPLASM ·+7
BLUEPOINT/ONCOP

FLUOROURACIL

5 FLUOROPYRIMIDINES · METASTATIC COLORECTAL CANCER ·+4
XIROMED, LLC

DECITABINE

PYRIMIDINE ANALOGS · MYELODYSPLASTIC SYNDROME
NOVADOZ-NOVAPLU

AZACITIDINE

PYRIMIDINE ANALOGS · MYELODYSPLASTIC SYNDROME ·+2
MEITHEAL-NOVAPL

AZACITIDINE

PYRIMIDINE ANALOGS · MYELODYSPLASTIC SYNDROME ·+2
Hikma Pharmaceuticals USA

DECITABINE

PYRIMIDINE ANALOGS · MYELODYSPLASTIC SYNDROME
Hikma Pharmaceuticals USA

DECITABINE

PYRIMIDINE ANALOGS · MYELODYSPLASTIC SYNDROME
FRESENIUS KABI

FLUOROURACIL

5 FLUOROPYRIMIDINES · METASTATIC COLORECTAL CANCER ·+4
FRESENIUS KABI
Filter & compare in the drug finder → Opens the drug finder with Pyrimidine Analogs preselected. Add indication or manufacturer filters there.

About Pyrimidine Analogs.

Pyrimidine analogs are a subclass of antimetabolite drugs structurally designed to mimic endogenous pyrimidines such as uracil, thymine, and cytosine.

By inhibiting essential nucleic acid synthetic enzymes—such as thymidylate synthase or DNA polymerase—or by directly incorporating into DNA and RNA to cause strand breaks and chain termination, these agents disrupt cell division and trigger apoptosis in rapidly dividing cells.

The class plays a fundamental therapeutic role in oncology, serving as frontline and maintenance treatments for hematologic malignancies and various solid tumors, including colorectal, breast, pancreatic, and gastric cancers.

Select pyrimidine-derived agents are also employed clinically to manage severe viral and fungal infections.